Medvantx’s Post

Why to choose Deconil (#Butamirate_Citrate)? ·        Proven cough suppressant ·        Mostly used to relieve dry (nonproductive cough) ·        Safe in extremes of ages ·        Non-sedative and hence used for pre and post-operative cough sedation before surgery and bronchoscopy ·        Can be used in acute cough of any etiology, whooping cough and cough due to acute lower respiratory tract infections ·        Widely used in productive cough with along with antibiotic or chemotherapeutic agent for faster cough suppression ·        Rapidly and completely absorbed after oral administration ·        Maximum concentration reaches within 9 hours ·        Plasma elimination half life is about 13 hours ·        Facilitates asthma patients through decreasing airway resistance Orion Pharma Ltd. offers Butamirate Citrate as- #Deconil 50 mg SR Tablet & Deconil7.5 mg/5 mL Syrup   For order/ distributorship please inbox or contact Email : [email protected] or [email protected] Whatsapp : 8801844637935 Website : www.orionpharmabd.com  #Healthcare #Medicine #Innovation #Nidazyl #Metronidazole #Health #Wellness #Treatment #MedicalScience #InfectiousDiseases #Efficiency #Safety #Trustworthy #QualityCare #MedicalInnovation #HealthTech #HealthyLiving #StaySafe #Research #Development #BacterialInfections #ProtozoalInfections #Giardiasis #BacterialVaginosis #GlobalHealth #Pharmaceuticals #OrionPharmaLtd

It's been an extraordinary journey with Lipogems International from our three landmark 510(k) clearances to two approved IDEs for the study of Knee OA in pursuit of a PMA. We have partnered with Carl Llewellyn, Amisha Patel, Giorgio Ninzoli and the team at Alira Health to advance these clinical trials toward PMA approval and the maximum reimbursement available. How can we help your firm accelerate development of Biologic products in #orthopaedics, #plasticsurgery, #woundcare or #aesthetics?

Why to choose Deconil (#Butamirate_Citrate)? ·        Proven cough suppressant ·        Mostly used to relieve dry (nonproductive cough) ·        Safe in extremes of ages ·        Non-sedative and hence used for pre and post-operative cough sedation before surgery and bronchoscopy ·        Can be used in acute cough of any etiology, whooping cough and cough due to acute lower respiratory tract infections ·        Widely used in productive cough with along with antibiotic or chemotherapeutic agent for faster cough suppression ·        Rapidly and completely absorbed after oral administration ·        Maximum concentration reaches within 9 hours ·        Plasma elimination half life is about 13 hours ·        Facilitates asthma patients through decreasing airway resistance Orion Pharma Ltd. offers Butamirate Citrate as- #Deconil 50 mg SR Tablet & Deconil7.5 mg/5 mL Syrup For order/ distributorship please inbox or contact mail : [email protected] Whatsapp : 8801844250962 Website : www.orionpharmabd.com  #Healthcare #Medicine #Innovation #Nidazyl #Metronidazole #Health #Wellness #Treatment #MedicalScience #InfectiousDiseases #Efficiency #Safety #Trustworthy #QualityCare #MedicalInnovation #HealthTech #HealthyLiving #StaySafe #Research #Development #BacterialInfections #ProtozoalInfections #Giardiasis #BacterialVaginosis #GlobalHealth #Pharmaceuticals #OrionPharmaLtd

"Odontogenic pain can be debilitating, and nonopioid analgesic options are limited. This randomized placebo-controlled clinical trial aimed to assess the effectiveness and safety of cannabidiol (CBD) as an analgesic for patients with emergency acute dental pain. Sixty-one patients with moderate to severe toothache were randomized into 3 groups: CBD10 (CBD 10 mg/kg), CBD20 (CBD 20 mg/kg), and placebo. We administered a single dose of respective oral solution and monitored the subjects for 3 h." Note: As this was conducted in the states, these doses are most likely CBD isolates and typically require higher doses. Always speak with your doctor or educator before increasing your dosage. "Both CBD groups resulted in significant VAS pain reduction compared to their baseline and the placebo group, with a maximum median VAS pain reduction of 73% from baseline pain at the 180-min time point (P < 0.05). CBD20 experienced a faster onset of significant pain relief than CBD10 (15 versus 30 min after drug administration), and both groups reached maximum pain relief at 180-min." https://lnkd.in/gFHbbZrh #Dental #Surgery #Recovery #Wellness #Heal #Odontegenic #Pain #ChronicPain #ToothAche #Headache #Migraine #Spoonie #CBD #MMJ #MEdical #Health #ONHealth #ONPoli #Canada

If you have something to say about #medicaldevices #sterilization and #endotoxin, this is a great time to get involved! Endotoxin of terminally sterilized devices has been getting a lot more attention since the updated FDA guidance on premarket submissions for sterile devices added "implants" to the list of products in scope for endotoxin limit criteria. There is some explanation in past versions of ST72 for the historical exclusion of orthopedic devices from endotoxin testing. There are a few current and upcoming projects for updating endotoxin standards: - AAMI/ST72:2019 is under review by AAMI ST/WG08 to look at updating the standard for better alignment with ISO 11737-3 and (possibly) to include some information on recombinant endotoxin testing as an alternative to LAL and (hopefully) to update some of the language related to sterilization effect on endotoxin based on some recent papers - ISO 11737-3 - published in 2023, this should come up for review next in 2028. Updates to the international standard are a bit harder to predict that far out and with more people involved but there is a good possibility that some of the updates going through now in ST72 will be reflected in future versions of the international standard. - USP <86> new general chapter "Bacterial endotoxin test using recombinant reagents". The latest news release I've seen on this has the expert committee voting around the last week of June with possible publication between November 2024 and May 2025 if approved.

🔃🟰❤️🩹 Let’s spread medical 🏥 knowledge folks, to reach those in need💖 Unlike standard surgical treatments for GERD, the minimally invasive ring treatment uses a tiny bracelet of magnetic titanium beads to surround and compress the lower esophageal sphincter. This valve normally prevents stomach fluids from refluxing into the esophagus. The magnetic attraction between the beads prevents gastric pressure from pushing open the muscle. The bracelet is flexible enough that the force of swallowing allows the beads, which are strung with titanium wire, to expand with the ring device expands as needed around the lower esophageal sphincternormal passage of food into the stomach. The Ring procedure generally takes less than an hour. It is performed laparoscopically, under general anesthesia. Because no surgical alteration of the stomach or the esophagus is needed, most patients are able to go home the day after surgery. Most are able to resume a normal diet immediately. In studies of the Ring system, which was approved in 2012 by the U.S. Food and Drug Administration to treat GERD, 90 percent of patients reported improvement in reflux symptoms or were able to eliminate medications a year after treatment. #medicaldevices #medtech #pharmaceuticals #healthcareleaders 💍

Vivani Medical today announced positive pre-clinical data on weight loss effects for its long-term exenatide implant. Vivani has its miniature, twice-yearly exenatide implant — NPM-115 — under development to treat chronic #WeightManagement. MORE ON THIS HERE: https://lnkd.in/gauVyVCx #WeightLoss #ClinicalData #Obesity #PreclinicalData #DrugImplant #ImplantTechnology Adam Mendelsohn

The volume of washout rinse after povidone iodine (PI) application for intravitreal injections (IVI) does not significantly affect patients’ ocular surface irritation, according to a study. Read the full article here ⤵️ #retina #ocularsurface #ocularsurfacedisease

💊𝗔𝗽𝗶𝘅𝗮𝗯𝗮𝗻 Apixaban is a novel oral anticoagulant, approved by FDA in 2012. ✨𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦 𝐨𝐟 𝐚𝐜𝐭𝐢𝐨𝐧: Apixaban is an oral inhibitor of factor Xa. It binds to the active site of factor Xa and inhibits conversion of prothrombin to thrombin. ⚕️𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐮𝐬𝐞: It is used for stroke prevention in non-valvular atrial fibrillation. It is also approved for treating deep venous thrombosis and pulmonary embolism. 🚫𝐀𝐝𝐯𝐞𝐫𝐬𝐞 𝐞𝐟𝐟𝐞𝐜𝐭𝐬: Bleeding is the most serious adverse effect for factor Xa inhibitors as there is no antidote available to reverse the bleeding caused by apixaban. Declining renal function can prolong the effect of the drug and increase the risk of bleeding. ⚠️𝐂𝐚𝐮𝐭𝐢𝐨𝐧: Don't stop apixaban abruptly. It increases the risk of stroke. Doctor may prescribe another anti coagulant to prevent clot formation. There is a risk of epidural or spinal hematoma, when apixaban is used with neuraxial anesthesia. 💊𝐃𝐨𝐬𝐞: 👉𝐒𝐭𝐫𝐨𝐤𝐞 𝐏𝐫𝐨𝐩𝐡𝐲𝐥𝐚𝐱𝐢𝐬 𝐰𝐢𝐭𝐡 𝐀𝐭𝐫𝐢𝐚𝐥 𝐅𝐢𝐛𝐫𝐢𝐥𝐥𝐚𝐭𝐢𝐨𝐧: 5mg PO BID 𝘙𝘦𝘯𝘢𝘭 𝘢𝘥𝘫𝘶𝘴𝘵𝘮𝘦𝘯𝘵: 2.5 mg BID if patient has serum creatinine ≥1.5 mg/dL, age ≥80 years or weight ≤60 kg. (If any 2 characteristics are present) 👉𝐃𝐞𝐞𝐩 𝐯𝐞𝐧𝐨𝐮𝐬 𝐭𝐡𝐫𝐨𝐦𝐛𝐨𝐬𝐢𝐬 𝐚𝐧𝐝 𝐩𝐮𝐥𝐦𝐨𝐧𝐚𝐫𝐲 𝐞𝐦𝐛𝐨𝐥𝐢𝐬𝐦: 10 mg PO BID x 7 days, then 5 mg BID 👉𝐏𝐨𝐬𝐭𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐏𝐫𝐨𝐩𝐡𝐲𝐥𝐚𝐱𝐢𝐬 𝐨𝐟 𝐃𝐕𝐓/𝐏𝐄: Indicated following hip or knee replacement surgery Initial: Give 2.5 mg PO 12-24 hr after surgery. Then 2.5 mg BID for 35 days for hip replacement surgery and for 12 days for knee replacement surgery. 🔴Discontinue at least 24 hours before surgery with low risk of bleeding and at least 48 hours before surgery with high risk of bleeding. 📍𝐑𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞𝐬: Medline plus medscape #apixaban #healthcare #pharmacist #medication #FDA